MSCLF
Price
$0.41
Change
-$0.01 (-2.38%)
Updated
Jul 25 closing price
Capitalization
68.29M
VYGR
Price
$3.24
Change
-$0.07 (-2.11%)
Updated
Jul 25 closing price
Capitalization
179.29M
4 days until earnings call
Interact to see
Advertisement

MSCLF vs VYGR

Header iconMSCLF vs VYGR Comparison
Open Charts MSCLF vs VYGRBanner chart's image
SATELLOS BIOSCIENCE
Price$0.41
Change-$0.01 (-2.38%)
Volume$60.45K
Capitalization68.29M
Voyager Therapeutics
Price$3.24
Change-$0.07 (-2.11%)
Volume$581.88K
Capitalization179.29M
MSCLF vs VYGR Comparison Chart in %
Loading...
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MSCLF vs. VYGR commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSCLF is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (MSCLF: $0.41 vs. VYGR: $3.24)
Brand notoriety: MSCLF and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MSCLF: 72% vs. VYGR: 86%
Market capitalization -- MSCLF: $68.29M vs. VYGR: $179.29M
MSCLF [@Biotechnology] is valued at $68.29M. VYGR’s [@Biotechnology] market capitalization is $179.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MSCLF’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • MSCLF’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than MSCLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MSCLF’s TA Score shows that 2 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • MSCLF’s TA Score: 2 bullish, 7 bearish.
  • VYGR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than MSCLF.

Price Growth

MSCLF (@Biotechnology) experienced а -5.58% price change this week, while VYGR (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($179M) has a higher market cap than MSCLF($68.3M). VYGR has higher P/E ratio than MSCLF: VYGR (6.32) vs MSCLF (2.24). MSCLF YTD gains are higher at: -30.017 vs. VYGR (-42.857). MSCLF has higher annual earnings (EBITDA): -19.92M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. MSCLF (41.2M). VYGR has higher revenues than MSCLF: VYGR (67M) vs MSCLF (0).
MSCLFVYGRMSCLF / VYGR
Capitalization68.3M179M38%
EBITDA-19.92M-97.25M20%
Gain YTD-30.017-42.85770%
P/E Ratio2.246.3235%
Revenue067M-
Total Cash41.2M236M17%
Total DebtN/A42M-
FUNDAMENTALS RATINGS
MSCLF vs VYGR: Fundamental Ratings
MSCLF
VYGR
OUTLOOK RATING
1..100
5077
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
32
Undervalued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
6364
P/E GROWTH RATING
1..100
759
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MSCLF's Valuation (29) in the null industry is in the same range as VYGR (32) in the Biotechnology industry. This means that MSCLF’s stock grew similarly to VYGR’s over the last 12 months.

MSCLF's Profit vs Risk Rating (80) in the null industry is in the same range as VYGR (100) in the Biotechnology industry. This means that MSCLF’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's SMR Rating (95) in the Biotechnology industry is in the same range as MSCLF (97) in the null industry. This means that VYGR’s stock grew similarly to MSCLF’s over the last 12 months.

MSCLF's Price Growth Rating (63) in the null industry is in the same range as VYGR (64) in the Biotechnology industry. This means that MSCLF’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for MSCLF (75) in the null industry. This means that VYGR’s stock grew significantly faster than MSCLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MSCLFVYGR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
76%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
77%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MSCLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMTO0.08N/A
+6.13%
RM2 International, Inc.
NEOJF11.53N/A
N/A
NEOJAPAN INC.
CGMLF1.20N/A
N/A
Chalice Mining Ltd.
CSUAY17.88N/A
N/A
China Shenhua Energy Co., Ltd.
DIFTY26.09-0.10
-0.38%
Daito Trust Construction Co.

MSCLF and

Correlation & Price change

A.I.dvisor tells us that MSCLF and ATHE have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MSCLF and ATHE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MSCLF
1D Price
Change %
MSCLF100%
-1.69%
ATHE - MSCLF
28%
Poorly correlated
+15.32%
AKBLF - MSCLF
28%
Poorly correlated
N/A
VYGR - MSCLF
27%
Poorly correlated
-2.11%
ABOS - MSCLF
26%
Poorly correlated
N/A
PEPG - MSCLF
26%
Poorly correlated
+0.69%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-2.11%
RGNX - VYGR
51%
Loosely correlated
-1.86%
KYMR - VYGR
49%
Loosely correlated
-0.13%
XNCR - VYGR
47%
Loosely correlated
N/A
IMNM - VYGR
46%
Loosely correlated
-3.29%
XENE - VYGR
46%
Loosely correlated
-2.29%
More